Musashi (Msi) is an evolutionarily conserved gene family of RNA-binding proteins (RBPs) that is preferentially expressed in the nervous system. The first member of the Msi family was identified in Drosophila. Drosophila Msi plays an important role in regulating asymmetric cell division of the sensory organ precursor cells. The mammalian orthologs, including human and mouse Musashi1 (Msi1), are neural RBPs that are strongly expressed in fetal and adult neural stem/progenitor cells (NS/PCs). Mammalian Msi1 contributes to self renewal of NS/PCs through translational regulation of several target mRNAs. In this study, the zebrafish Msi ortholog zMsi1 was identified and characterized. The normal spatial and temporal expression profiles for both protein and mRNA were determined. A series of splice variants were detected. Overall, zMsi1 was strongly expressed in neural tissue in early stages of development and exhibited similarity to mammalian Msi1 expression patterns.
Introduction
Musashi (Msi) was first identified in the external sensory organ in the peripheral nervous system (PNS) of Drosophila and is required for asymmetric cell division of the sensory organ precursor (SOP) cell of the Drosophila adult external sensory organ, and it functions by controlling the expression of Tramtrack69 (TTK69) (Nakamura et al., 1994) . Msi contains two RNA recognition motifs (RRMs) as a highly conserved RNAbinding domain. Msi belongs to a distinct gene family that is phylogenetically conserved from invertebrates to vertebrates. Msi is expressed in neural tissues in both the central nervous system (CNS) and PNS Okano et al., 2005) . Members of the Msi family include Drosophila Msi, and ascidian MUSASHI from Halocynthia roretzi and Ciona intestinalis (Kawashima et al., 2000) in invertebrates. Vertebrate Msi family members include the frog (Xenopus laevis) nervous systemspecific RNP protein-1 (Nrp-1) (Richter et al., 1990; Sharma and Cline, 2010) , torafugu (Fugu rubripes) Msi-1 (Aparicio et al., 2002) , chicken (Gallus gallus) Msi1 (Asai et al., 2005; Wilson et al., 2007) , mouse (Mus musculus) Msi1 (Sakakibara et al., 1996) , and human (Homo sapiens) MSI1 (Good et al., 1998) . The mouse Musashi2 (Msi2) exhibits high similarity to Msi1 in primary structure, RNA-binding specificity and CNS expression pattern. Msi2 acts cooperatively with Msi1 in the proliferation and maintenance of NS/PCs . Human MSI2 was identified during the course of research examining disease progression in chronic myeloid leukemia (Barbouti et al., 2003; Ito et al., 2010; Kharas et al., 2010) .
Among Msi family members, mouse Msi1 is highly enriched in developing NS/PCs (Sakakibara et al., 1996) and is thought to contribute to the maintenance of the NS/PCs by regulating the translation of particular downstream target genes Sakakibara et al., 2002) , such that Msi1 competes with eIF4G for binding to PABP, both of which are general translation factors (Kawahara et al., 2008) .
In this study, we report the sequence and characterize the function of the zebrafish (Danio rerio) Msi family member. One experiment essential for revealing the function of a protein is a loss-of-function study using an animal model. However, the postnatal survival rate of msi1 knockout mice is very low and determination of the adult phenotype has not been possible. Thus, we used zebrafish as a new animal model for this Msi analysis because of their transparent body, which enables detailed observations of development. Furthermore, manipulation of zebrafish, for example, by zmsi1 knock down (KD) by morpholino oligonucleotides (MOs), is relatively easy compared to mice.
This zebrafish model will be an excellent tool with which to study the in vivo functions of Msi. Our present results illustrate the use of this animal model to reveal the roles of zebrafish Msi1 (zMsi1) in CNS development and its potential use as a neurological disease model.
Results

Molecular cloning and sequence analysis of zebrafish Msi1
The database of zebrafish cDNA sequences contains several fragmented and incomplete sequences of Msi1. Full-length cloning primers were designed using the deposited sequences. To clone zebrafish Msi1, RT-PCR was performed Fig. 1 -Molecular cloning and sequence analysis of zebrafish Msi1. Putative Msi1 amino acid sequences were compared between human, mouse and zebrafish (1A). Exon-intron structure analysis with newly cloned Msi1 cDNA and the genomic sequence from zebrafish chromosome 8 suggests that the full-length sequence of zMsi1 consists of 14 exons (1B). The blue boxes indicate the 3′ and 5′ untranslated regions, the black boxes show the common exons, and the red boxes indicate the alternative exons (4 and 11). Diagrammatic comparison of three transcript variants from putative Msi1 in zebrafish is summarized in Fig. 1C . The green boxes show the common amino acid sequence, the red boxes show sequence derived from alternative exons, and the lined box on zMsi1 + 35 bp indicates the frame shifted sequence and the premature termination codon.
using total RNA obtained from the brain of 5-week-old wildtype zebrafish (RIKEN WT), and identified a 2.3-kb cDNA clone that contained the putative full-length coding sequence of zMsi1. In mouse, Msi1 has two alternatively spliced isoforms. In the zebrafish gene, as in the mouse, zMsi1 has two alternative exons as confirmed by sequencing results from several clones amplified using two sets of cloning primers (Fig. 1A) . The full length putative protein sequences are highly conserved with other species including mouse (83%) and human (84%). The extent of sequence conservation is high throughout the length of the protein, with the two RRM domains (black bars) exhibiting an even higher degree of sequence identity with mouse (RRM1; 89%, RRM2; 94%) and human (RRM1; 89%, RRM2; 95%).
From the results of a BLAST search of the zebrafish genomic sequence using the zebrafish Msi1 cDNA as a query, the Msi1 gene was found to have 14 exons on chromosome 8, and three putative zebrafish Msi1 transcripts were identified (Fig. 1B) . The shorter form of zebrafish Msi1 (zMsi1S) skips exons 4 and 11 (in red), producing a 2303 nucleotide sequence that is translated into a 330 amino acid polypeptide with a predicted molecular weight of 35.9 kDa. The longer form of Msi1 (zMsi1L) skips exon 4 (in red), producing a 2360 nucleotide sequence that is translated into 349 amino acids with a predicted molecular weight of 38.0 kDa. Thus, zMsi1L is 19 amino acids longer than zMsi1S. Approximately half of the zMsi1 cDNA is zMsi1L (six out of 13 clones) and the remainder is primarily zMsi1S (five out of 13 clones). A minor splicing variant is the zMsi1L + 35 bp clone, which contains exon 4 and produces a 129 amino acid polypeptide caused by a premature stop codon in exon 6 following the inclusion of exon 4 ( Fig. 1C and Supplementary Fig. 1 ). In database searches, only the transcript variant for zMsi1S was detected.
2.2.
Phylogenetic analysis of zebrafish Msi1 cDNA
The nucleotide sequence of the zMsi1 cDNA was compared with its orthologs in human, mouse, rat, chick, Xenopus, C. elegans, ascidian (H. roretzi and C. intestinalis) and Drosophila. The protein sequences of Msi1 and Msi2 from eight species were multiply aligned using the UPGMA method with the Genetyx software. A phylogenetic tree was inferred by neighbor- Fig. 2 -Phylogenetic analysis of putative Msi1 proteins from several species. From the comparison of amino acid sequences, the phylogenetic tree was constructed using the UPGMA method via the Genetyx software. The putative Msi1 protein in zebrafish has the highest similarity to Nrp-1, a Xenopus Msi family member. 
2.3.
Genomic structure of the Msi1 gene in zebrafish
Comparing the genomic sequence of Musashi family genes with those of several other species, the exon-intron structures of the genes were found to be mostly preserved between the human, mouse and zebrafish (Fig. 3) . The human MSI1 consists of 15 exons spanning a 28-kb genomic region on chromosome 12. The mouse Msi1 also consists of 15 exons spanning a 25-kb genomic region on chromosome 5. The newly identified zebrafish Msi1, which is located on chromosome 8, spans approximately 40.3 kb. The putative Msi1 gene from F. rubripes also has a similar structure with 15 exons. Interestingly, the Fugu genome size is quite small for a vertebrate, being approximately oneeighth the size of the human genome. However, the putative Fugu Msi1 gene is one of the largest among all genes (~176 kb), being approximately six-times larger than the human MSI1 in size (Aparicio et al., 2002; Brenner et al., 1993) . The compactness of the Fugu genome is thought to be the result of the deletion of unnecessary repeated sequences and minimization of intronic regions. However, for the Fugu Msi1 homolog this is apparently not the case, and is contrary to current hypotheses regarding exon-intron structure evolution.
We next focused on the intronic enhancer region designated D5E2, which, in mouse, is responsible for transcriptional regulation of Msi1 (Kawase et al., 2011) . The intronic D5E2 enhancer element is highly conserved among several mammalian species; however, this conserved element was not detected in chick, zebrafish or Fugu. The conservation of the D5E2 intronic enhancer in a few species suggests the acquisition of different mechanisms of gene regulation in Msi1 evolution.
2.4.
Msi1 mRNA expression profiling during development using RT-PCR To explore the temporal distribution patterns of zMsi1 mRNA, total RNA was prepared from animals at several developmental stages, from just after fertilization to the adult stage. A semi-quantitative RT-PCR analysis was performed with primer sets to detect total zMsi1 mRNA levels or expression of an internal control (β-Actin). Only a small amount of total zMsi1 expression was detected at 0 and 6 hours post-fertilization (hpf). The zMsi1 mRNA level increased dramatically from the shield stage, 12 hpf, and its expression was maintained through to 12-month-old zebrafish in the brain (Fig. 4A ), suggesting that zMsi1 expression is initiated after the maternalzygotic transition.
To distinguish the splicing variants of zMsi1, we designed new primers for sequences in exon 10 and 12 that distinguish between the zMsi1L and zMsi1S transcripts. The long form of zMsi1 is the major form expressed in all examined developmental stages. However, a small amount of mRNA for the short form of zMsi1 was detected in 48-hpf and older embryos (Fig. 4B ). These results indicated that total zMsi1 expression was mainly zygotic and similar to the type of genes expressed in the pharyngula stage (Mathavan et al., 2005) .
Another primer set for sequences in exon 3 and 5 was used to distinguish transcripts containing the 35 base pairs of exon 4 (Fig. 4C ). Small amounts of zMsi1 mRNA with the 35 bp alternative exon were specifically detected after 24 hpf. This observed minor population of zMsi1L + 35 bp mRNA may be the result of RNA degradation by the nonsense-mediated mRNA decay (NMD) pathway. These RT-PCR results demonstrated the predominance of zMsi1L mRNA. However, the functional differences between the three variants still remain unclear.
2.5.
Spatial expression analysis of zMsi1 with whole mount in situ hybridization Next, to elucidate the spatial expression patterns of zMsi1 mRNA in the zebrafish, we performed whole mount in situ hybridization with 24-and 48-hpf embryos. A zMsi1 antisense probe detected endogenous mRNA in some parts of the brain, spinal cord and eyes (Figs. 5A, C) . The 48-hpf sample with antisense probe showed restricted expression of zMsi1 Fig. 3 -Genomic structure of Msi gene loci of zebrafish and other species. Exon-intron structures in Musashi family genes were compared among several species. In mammals, human and mouse Msi1 consists of 15 exons over 28 kb and 15 exons over 25 kb of genomic DNA, respectively. In the zebrafish genome, zMsi1 has 14 exons covering 40.3 kb of genome sequence. Intriguingly, the Msi1 gene in Fugu, which is well known for its minimized genome size, has 14 exons covering 176 kb of the genome. Arrowheads: the human and mouse D5E2 intronic enhancer region of Msi1.
in the forebrain in embryos and no signal was detected in the spinal cord (Fig. 5C ). These results indicate that zMsi1 is expressed mainly in the CNS in zebrafish embryos and we hypothesized that zMsi1 may play important roles in the development of the CNS in vivo.
Developmental stage-dependent expression profiling of zMsi1 protein
To evaluate Msi1 protein levels at each developmental stage, we performed immunoblotting with a rat monoclonal anti-mouse Msi1 antibody (14H1) that was described previously (Kaneko et al., 2000) . Protein lysates were prepared from whole embryos or isolated heads of wild-type zebrafish, homogenized at 2, 3, 4 days and 5 months post-fertilization. The same amount of mouse brain lysate from embryonic day 14.5 was loaded as a positive control (Fig. 6A) . The amounts of protein loaded in each lane were referenced with that of internal control antibodies against α-Tubulin and β-Actin (Fig. 6B) .
The recognition sequence for the 14H1 monoclonal antibody is highly conserved (nine out of ten amino acids are identical between mouse and zebrafish) (Fig. 1A, blue bar) . A single band at approximately the size of mouse Msi1 (362 amino acids) was detected at each stage. Mouse Msi1 is only 13 amino acids longer than zMsi1L (349 amino acids). Several faint non-specifically stained bands were present in the zebrafish samples.
The zMsi1 protein was detected at day 2 (48 hpf), and the expression levels gradually increased in an age-dependent manner in the 2-7-day-old zebrafish (Fig. 6A) . In adult zebrafish with an age of 5 months, zMsi1 expression was much Fig. 4 -RT-PCR analysis of temporal expression patterns of zMsi1. RT-PCR was performed using fertilized eggs to 12-month-old zebrafish, in order to detect total zMsi1 and three splice variants: zMsi1L(long), zMsi1S(short), and zMsi1L + 35 bp. The total zMsi1 expression level increased from 0 h to 0.5d (12-hpf) and reached a plateau at 12 hpf until 12 months. β-Actin was used as a internal loading control (A). The zMsi1S expression level appeared at approximately 48 hpf, increased gradually by 3.0d (72-hpf), and the level was maintained for 12 months (B). The mRNA level of zMsi1L + 35 bp appeared in 24-hpf embryos, increased gradually to approximately 2.0d (48-hpf), and the level was maintained for 12 months (C). Fig. 5 -Whole mount in situ hybridization using a zMsi1 probe. Whole mount in situ hybridization of 2.0d (48-hpf) and 3.0d (72-hpf) embryos was performed using a zMsi1 probe. The zMsi1 mRNA was highly expressed in the brain, eyes and part of spinal cord in the 24-hpf (A), and 48-hpf (C) embryos. As a negative control, in situ hybridization using the sense zMsi1 probe is shown in 24-hpf (B) and 48-hpf (D) embryos. Scale bars: 200 μm.
higher than in embryonic stages. By contrast, in the mouse, the level of Msi1 is highest in the early embryonic period, and its levels are much lower in the adult brain. Taken together, these results show that the expression profile of Msi1 in zebrafish was different from that in mouse.
Protein localization of zMsi1 was evaluated via immunohistochemistry in day 2 (48 hpf) zebrafish embryos (Figs. 6C-G) . Many cells in the CNS and the eyes expressed zMsi1, which exhibited an expression pattern similar to that of the proliferative cell marker, PCNA (Fig. 6C) . Cells positive for cytoplasmic Msi1 were co-labeled with anti-PCNA in the forebrain, midbrain, hindbrain and eyes (Figs. 6D-G) .
2.7.
Phenotypes of zebrafish with morpholino KD of zmsi1
To evaluate the functions of Msi1 in zebrafish development, we constructed and injected MOs into one-cell stage wildtype zebrafish embryos to knock down expression of zMsi1.
To evaluate the survival rate and observe specific phenotypes in the MO-injected group, the following controls were prepared: non-injected (injection minus) wild type (Fig. 7A ) and randomized sequence MO-injected wild type (Fig. 7B) . Two phenotypes were detected in zMsi1 MO-injected embryos: mild and severe. The frequencies of the mild and severe phenotypes were quantitatively evaluated as shown in Figs. 7B-D. Approximately 14% of zmsi1 KD embryos exhibited a severe phenotype in which the embryo had a very small head and tail, and insufficient formation of the eyes (Fig. 7C) . The severe group appeared to also have pericardial edema. Another 46% of zmsi1 KD exhibited a mild phenotype, in which the embryo showed a slight microcephaly and lateral curvature of the shortened spine and fin (Fig. 7D) . In both cases, these zebrafish embryos could not swim normally and the mortality rate was higher than for the control groups (Fig. 7E) . The frequency of the microcephaly phenotype is shown in Fig. 7F . Representative embryos defining the normal, mild and severe phenotypes are shown in Figs. 7B-D. To confirm the reproducibility of the KD phenotype, a second MO experiment was performed, in which a 25-bp MO with a completely different sequence was used to target zmsi. The frequencies of the phenotypes were similar to the first MO KD (Fig. 7F) .
To confirm the phenotype specificity, we next performed rescue experiments with purified recombinant protein from several species (Supplementary Fig. 2A ). The frequency of Fig. 6 -Age-dependent protein expression profiling of zebrafish Msi1. The protein level of zMsi1 was evaluated by immunoblotting with a rat monoclonal anti-mouse Msi1 antibody. Bands at approximately 40 kD were detected with mouse and zebrafish protein lysates from the indicated stages. The zMsi1 expression was upregulated in an age dependent manner (A). Some non-specific bands were observed in the zebrafish lysate. Constant expression of α-Tubulin and β-Actin were confirmed as an internal loading control (B). Protein localization of zMsi1 was evaluated via immunohistochemistry in frozen sections of 2-day-old (48-hpf) zebrafish embryos using a rabbit anti-mouse Msi1 polyclonal antibody and an antibody specific for the proliferative cell marker PCNA (C). The zMsi1 protein was localized primarily in the cytoplasm in the CNS and eyes in cells that were co-labeled with anti-PCNA in the forebrain (D), midbrain (E), hindbrain (F) and eye (G). Scale bars: 100 μm (C) and 10 μm (D-G).
the microcephaly phenotype decreased with the injection of zebrafish, mouse or human Msi1 protein, which were purified via their HA-tags (Fig. 7F) . A statistical analysis comparing the frequency of the rescued phenotype between the KD and rescued samples indicated that the only significant difference was in the severe phenotype group. The severe phenotype was rescued by zMsi1 injection (p = 0.003), as well as by injection of the mouse (p = 0.013) or human (p = 0.010) protein.
Injection of the zMsi1 protein without MO resulted in a significant increase in whole body size by day 3 (72 hpf) compared to wild-type embryos ( Supplementary Figs. 2C-E) . The reason why this over-expression phenotype was not restricted to the CNS is unclear; however, the injected HA-tagged protein was detected diffusely throughout the entire embryo.
To examine the hypoplasia of the CNS, a specific marker transgenic zebrafish was used. The green fluorescent protein (GFP) transgenic zebrafish Tg (elavl3:EGFP)zf8 (Park et al., 2000) , designated HuC:GFP, was used in a zmsi1 KD analysis. The HuC:GFP transgenic strain was used to observe neural tissue formation over the course of development because the expression of GFP is controlled by the promoter of a neural tissue-specific RBP, HuC (Figs. 7G-J) . In the zmsi1 KD in HuC: GFP zebrafish, a limited number of GFP positive cells were detected due to hypoplasia of the neural tissue in both the brain and spinal cord (Figs. 7G and H) .
Finally, the effectiveness of the MO KD of zMsi was evaluated by anti-Msi1 immunohistochemistry using frozen sections from 48 hpf embryonic spinal cord. Expression of zMsi1 was absent in the MO-injected embryo compared to embryos injected with the control MO (Figs. 7K and L) .
These results suggest that zMsi1 has essential roles in the development of zebrafish embryos. Considering the reported functions of Msi1 in mouse and human, the current results indicate that zMsi1 also contributes to the formation and/or the maintenance of the developing CNS in zebrafish.
Discussion
In this study, we showed that zebrafish Msi1 has high sequence similarity to human and mouse Msi1 (Figs. 1 and  2 ). The temporal expression of the zebrafish Msi1 protein was slightly different from that of mouse (Fig. 3) . However, whole mount in situ hybridization suggested that zMsi1 is enriched in the developing CNS, similar to mammalian systems (Fig. 5) . Some of these differences may be partially due to the fact that constitutive turnover of neurons is more frequently observed in zebrafish than in mammals (Grandel et al., 2006) . MO injection experiments (Fig. 7) indicated that zMsi1 plays important roles in the development of embryos, particularly in the CNS, similar to that of mouse and human. In vertebrates, another Msi family gene, Msi2, has been reported (Barbouti et al., 2003; Sakakibara et al., 2001) . In mouse, Msi2 acts cooperatively with Msi1 in the proliferation and maintenance of NS/PCs. Therefore, zMsi may play similar roles to those of mouse Msi. Future studies should examine the role of Msi2 in zebrafish and elucidate the functional relationships between Msi1 and Msi2.
The major phenotype of msi1-deficient mice is developmental obstructive hydrocephalus, and the mice die within a month of birth (Sakakibara et al., 2002) . In humans, a number of reports have indicated that Msi1 expression is highly upregulated in a variety of diseases, such as brain tumors (Hemmati et al., 2003; Kanemura et al., 2001; Nakano et al., 2007; Sanchez-Diaz et al., 2008; Yokota et al., 2004) , alimentary tract tumors (Bobryshev et al., 2010; Sureban et al., 2008) and breast tumors (Wang et al., 2010) . The analysis of Msi2 in humans suggests that Msi2 may play a role in disease progression in chronic myeloid leukemia (Barbouti et al., 2003; Ito et al., 2010; Kharas et al., 2010) . Indeed, some of the targets of Msi are involved in cell cycle regulation. For example, Msi1 regulates translation of p21 cip1 , which is one of the important inhibitors of cell cycle progression (Battelli et al., 2006; Gotte et al., 2011) . Thus, Msi family members may play important roles not only in the development of the nervous system, but also in cell cycle regulation. Additionally, Msi expression is correlated with impaired cell cycle control and malignancy in several diseases (Ito et al., 2010; Kanemura et al., 2001; Kharas et al., 2010; Sureban et al., 2008; Wang et al., 2010) . In this study, we observed hypoplastic formation of the CNS due to neural differentiation and/or cell cycle progression defects in zmsi1 KD-HuC:GFP transgenic zebrafish (Fig. 7) . However, a more detailed study will be required to determine how zMsi1 interacts with its downstream effectors in the regulation of neurogenesis and cell cycle progression.
The results of the zMsi1 expression analysis (Figs. 5 and 6) showed that zMsi1 was expressed in the CNS, including the telencephalon, and could be involved in neurogenesis in this region. Zebrafish miR-9 (z-miR-9) is expressed in the telencephalon from 20 to 24 hpf, and inhibits the in vivo expression of Her5 and Her9 mRNAs, mouse Hes basic helixloop-helix transcription factor orthologs, and neural repressors (Leucht et al., 2008) . Interestingly, mMsi1 regulates Hes expression by binding to the 3'UTR of the m-numb mRNA and controlling its translation ). Alternatively, Msi1 enhanced the expression of the miR-9 directed reporter conjugated to the Nr2e1 3'UTR (Shibata et al., 2011) . Our recent study reported that Msi1 regulates miRNA processing of the let-7 family member mir-98, which acts as a Lin28-enhancer protein during early neural differentiation of ES cells (Kawahara et al., 2011) . These results suggest that zMsi1 also may be involved in neurogenesis and tumorigenesis via miRNA processing and translational control of its direct targets. However, it will be Fig. 7 -Knock down of zmsi1 by morpholino injection in zebrafish embryo. The morpholino oligonucleotides (MOs) were injected into wild-type zebrafish one-cell stage embryos. As a control, non-injected eggs (wild type) (A) and randomized sequence control MO-injected (control) (B) groups were prepared. Morphologically, the msi1 MO-injected animals showed two phenotypes, severe and mild microcephaly (C and D). The survival rates of the wild type, control and zmsi1 MO-injected groups were compared. There were no significant differences; however, the injected groups, especially the zmsi1 MO-injected group, showed higher mortality rates (E) (p= 0.33 at day 2, p = 0.06 at day 3). The frequencies of the phenotypes among the embryos that survived for 48 h after MO injection are indicated in Fig. 7F , according to the classifications in Fig. 7B-7D (severe, mild and normal). To eliminate off-target effects of the MO KD, the microcephaly phenotype was evaluated with another zmsi1 MO, which had a different sequence. The frequencies of the phenotypes were similar to the first MO. The frequency of the mild and severe microcephaly phenotypes decreased with a rescue experiment in which zMsi1, mouse Msi1, or human MSI1 were co-injected with the MO (F). MO-injection experiments using the HuC;GFP transgenic zebrafish, in which neural tissue is labeled with GFP fluorescence, were performed. A limited number of GFP + neural lineage cells were observed in the zmsi1
MO-injected group (G-J).
To confirm the efficiency of the MO KD, zMsi1 expression was examined by anti-Msi1 immunohistochemistry. In the spinal cord, high zMsi1 expression was detected in the control MO-injected group, whereas zMsi1 was completely absent from the zmsi1 MO-injected group (K and L). Scale bars: 500 μm (A-D, G-J), 20 μm (K, L).
essential to identify bona fide RNA target genes of Msi in a genome-wide screen to predict candidate downstream effectors in development. Then, the involvement of zMsi regulatory pathways in neural development could be clarified by in vivo manipulations using our zebrafish model. Further analysis of Msi function using this novel zebrafish model will provide new insights into human neurological diseases that are linked to a failure in normal brain development.
Experimental procedures
Animals
For this study, the RIKEN WT (RW) zebrafish was used as the control wild-type strain of D. rerio. The HuC:GFP (Tg (elavl3:EGFP)zf8
) transgenic D. rerio (Park et al., 2000) expressing GFP as a neural tissue marker was obtained from the RIKEN bioresource center. The completely transparent samples shown in Figs. 5 and 7 were prepared by treating fertilized eggs with 0.1 mM phenylthiourea (PTU) to block pigment formation. All experimental procedures were approved by the Institutional Recombinant DNA Committee, and the Animal Care and Use Committee of Keio University.
4.2.
RNA purification for molecular cloning and semi-quantitative RT-PCR Total RNA from different stages of zebrafish fertilized eggs and embryos and from adult brain were isolated using the Trizol reagent (Invitrogen) according to the manufacturer's instructions. First strand cDNA synthesis was performed with 1 μg total RNA and oligo-d(T)12-18 primers at 42°C for 50 min according to the manufacturer's instructions (Superscript III, Invitrogen). Cloning of zMsi1 was performed using Taq DNA polymerase (Invitrogen) PCR with the following primer sets: zMsi1F, 5′-CTTTTCTCGCACCAGACTCGG-3′, and zMsi1R, 5′-TCAGAGAGGGTCCAGCTTCAA-3′; zMsi1F_XbaI, 5′-AATCTAGAATGGAATCGGAAGGCAGCCA-3′, and zMsi1R_X-baI, 5′-AATCTAGAATGGTAGCCATTAGTAAATG-3′, in the pGEM-T-Easy cloning vector (Promega). Semi-quantitative RT-PCR was carried out using a KOD Plus kit (Toyobo) according to the manufacturer's instructions in a final volume of 25 μl with the following primer sets: zm1set1_F, 5′-GACCAGA-CATGAGCTGGACT-3′, and zm1set1_R, 5′-GTCCGAGTGAC-CAACTTAGG-3′; zm1Set2_F, 5′-CAGGGTTCCAGGCAACAACA-3′, and zm1Set2_R, 5′-GAGTTGAGCCTCTGACCACA-3′. To analyze relative expression of different stage mRNAs, the amount of cDNA was normalized based on the signals from ubiquitously expressed β-actin mRNA (beta-actin5, 5′-GACCTGACAGAC-TACCTGAT-3′, and beta-actin3, 5′-AGACAGCACTGTGTTGG-CAT-3′). To provide negative controls and exclude contamination by genomic DNA, the reverse transcriptase was omitted in the cDNA synthesis step, and the samples were subjected to the PCR reaction in the same manner with the same primer sets as indicated above for RT-PCR (−). PCR products were separated by electrophoresis in agarose or polyacrylamide gels, and the bands were visualized with ethidium bromide on an Alphaimager (Alpha Innotech). The identity of all the PCR products was confirmed by sequencing. All obtained sequences were analyzed with the Genetyx software version 7.0 (GENETYX CORPORATION).The sequence was submitted to GenBank (Accession number; AB698464, AB698465, AB698466).
Whole mount in situ hybridization
In situ hybridization of zebrafish was performed as described previously (Makino et al., 2005) . Briefly, samples were fixed overnight at 4°C in 4% paraformaldehyde in phosphatebuffered saline (PBS), washed briefly in two changes of PBS-0.1% Tween 20 (PBT), and transferred to 100% methanol for storage at −20°C. The samples were rehydrated stepwise through methanol in PBT and then washed in four changes of PBT. Subsequently, samples were incubated with 10 μg/ml proteinase K in PBT for 15-60 min and rinsed twice in PBT before a 20-min refixation. After washes in five changes of PBT, samples were prehybridized at 65°C for 1 h in buffer consisting of 100% formamide, 20x SSC, 0.1% Tween 20, 10 mg/ml heparin, 9 mM citric acid, and 50 mg/ml yeast RNA and then hybridized overnight in hybridization buffer containing 0.5 mg/ml digoxigenin-labeled RNA probes with the sense or anti-sense sequence. Labeling of the RNA probe was performed with a labeling kit (Roche) using the pGEM-T-Easy vector cloned zMai1 sequence, which is common to all splice variants of zMsi1, and the probe was confirmed by sequencing. Samples were then washed at 65°C for 10 min each in 75% hybridization buffer/25% 20x SSC, 50% hybridization buffer/50% 20× SSC, and 25% hybridization buffer/75% 20× SSC, followed by two washes for 30 min each in 0.2× SSC at 65°C. Further washes for 5 min each were conducted at room temperature in 75% 0.2× SSC/25% PBT, 50% 0.2× SSC/50% PBT, and 25% 0.2× SSC/75% PBT. After a 1-h incubation period in PBT containing 2 mg/ml bovine serum albumin, samples were incubated for 2 h in the same solution with a 1:2000 dilution of sample-preabsorbed anti-digoxigenin antibody. After washes in changes of PBT for approximately 2 h, samples were washed three times in reaction buffer (1 M Tris-HCl, pH 9.5, 1 M MgCl 2 , 5 M NaCl, 0.1% Tween 20, 1 M levamisol) and then incubated in reaction buffer with 1 × NBT/BCIP substrate. In general, positive signals were obtained after 0.5-1 h incubation in substrate. Following the staining reaction, samples were washed in several changes of PBT, fixed in 4% paraformaldehyde in PBS, and then washed in five changes of PBT. The samples were then hydrated through methanol twice and transferred to 75% glycerol for observation and storage at −4°C. For each probe, approximately 10 samples were examined for expression at 24 and 48 hpf.
Immunoblotting
The detailed immunoblotting procedure has been described previously (Yano et al., 2005) . Briefly, the indicated tissues were minced and sonicated in lysis buffer (10 mM Tris-HCl, pH 7.6, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitor mixture) to obtain a protein lysate. After centrifugation, the concentrations of the supernatants were measured, and equal amounts of total protein were solubilized by boiling in loading buffer, separated by SDS-PAGE, and transferred to an Immobilon P-membrane (Millipore). The blots were probed with rat anti-mouse Msi1 (1:1000, clone 14H1) (Kaneko et al., 2000) , rat monoclonal anti-HA antibody (1:2000 Roche), mouse anti-α-tubulin (1:5000 Sigma) or mouse anti-β-actin (1:2000, Sigma) primary antibodies and HRP-conjugated anti-rat and anti-mouse IgG secondary antibodies (1:1000, Jackson Immuno Res.). Antibody binding was visualized by ECL (GE healthcare), and detected and quantified using an LAS3000 imager (Fujifilm).
Immunohistochemistry
The detailed procedure for immunohistochemistry has been described previously (Shibata et al., 2010) . Briefly, at day 2 (48 hpf), embryos were fixed with 4% PFA, and 14-μm thick cryosections were prepared using a cryostat (CM3000, Leica). Antigen retrieval was performed by incubating the samples with 10 mM citric acid solution (pH 6.0) in an autoclave at 105°C for 10 min. The sections were incubated overnight at 4°C with specific primary antibodies [rabbit polyclonal antimouse Msi1 (1:200) (Sakakibara et al., 1996) , and mouse monoclonal anti-PCNA (1:200, NA03(Ab-1), Oncogene)], followed by a 1 h incubation at room temperature with the appropriate secondary antibodies conjugated with Alexa488 or Alexa555 (Invitrogen) together with Hoechst 33258 (10 μg/ml, Sigma) for nuclear staining. The samples were examined with a laser scanning confocal microscope (LSM700, Carl Zeiss).
Microinjection of morpholinos
A specific antisense MOs used to knock down msi1 expression in zebrafish was designed and produced by Gene Tools, LLC (Philomath, OR). The sequences of MOs used in these experiments were zmsi1-1 MO, 5′-TACTTTGGCTGCCTTCCGATTCCAT-3′ and zmsi1-2 MO, 5′-TCCCGTCCGAGTCTGGTGCGAGAAA-3′. Standard control MOs were also obtained from Gene Tools. The MOs were dissolved to a final concentration of 0.3 mM in distilled water and mixed with 0.05% phenol red solution (P0290, Sigma). A total of 1 nl was injected into one-cell stage embryos with an IM300 microinjector (Narishige). MO-injected zebrafish embryos were incubated at 28.5°C, observed using an AZX16 microscope (OLYMPUS) and recorded by Dynamic Eye REAL imaging software (MITANI CORPORATION). Fluorescence images of HuC:GFP transgenic zebrafish were captured with a BZ-9000 camera (Keyence).
Msi1 expression vector preparation and protein purification
The zebrafish, mouse and human Msi1 coding sequences were prepared using TA-cloning with the pGEM-T-Easy kit followed by sequencing to confirm the constructs. The HAtagged expression vectors in pcDNA3 were prepared by ligation of the HA tag sequence to the protein coding sequence (pcDNA3-HA-zebrafishMsi1, pcDNA3-HA-mouseMsi1, pcDNA3-HA-humanMSI1) and expression was confirmed by immunoblotting ( Supplementary Fig. 2A ). Purified protein was obtained from lysates of transfected 293T cells (FuGene6) using an anti-HA affinity matrix in column according to the manufacturer's instructions (clone 3F10, from Roche).
Statistical analysis
All data are presented as the mean ± SE. Statistical significance was tested using the unpaired two-tailed Student's t-test.
